In today’s Pharmaceutical Executive Daily, learn how Abbott is acquiring Exact Sciences in a major diagnostics deal, Novartis ...

Tesaro confirmed its litigation against AnaptysBio in the Delaware Chancery Court in a press release on its website, ...

Pharmaceutical collaborations expand as Flagship Pioneering expands its partnership with GSK, signing agreements with ...

Jay Bregman, co-founder of Andel, the cost and operational complexity of covering GLP-1 medications.

In the first part of our conversation with Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings Institution, he provides a broad overview of the possible positive and negative ...

From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...

Moderna has announced a $140 million investment to enhance its Massachusetts manufacturing capacity, a move that supports ...

Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...

Cancerguard, a multi-cancer early detection blood test.

In the first part of our conversation with Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings ...

AbbVie and Genmab have received FDA approval for Epkinly as a treatment option for patients with relapsed or refractory follicular lymphoma. The decision adds a new targeted immunotherapy to the ...

Just a few weeks after the company announced licensing agreements with Empirico and Syndivia, GSK announced a strategic ...